L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
A recent clinical study has been released, evaluating the ocular and peri-ocular tolerance and the efficacy of TOLERIANE DERMALLERGO EYES.
The open study La Roche-Posay conducted, included male and female subjects of the caucasian type, over the age 18 who show palpebral eczema or sensitive skin, especially around the eyes.
Already 10 min after application, TOLERIANE DERMALLERGO EYES shows an average reduction of 26% on the intensity of the below listed functional signs. After 14 days of application, the average decrease of proportion is 41%. Finally, after 28 days of use there is a general reduction of 63% for the investigated functional signs.
After 14 and 28 days TOLERIANE DERMELLERGO EYES significantly lowers the intensity of the following physical signs with a minimum of 55%:
Illustrative photo, mean case
Next, a self-assessment and clinical evaluation by dermatologists was included in the study. Thanks to its soothing and repairing action:
Finally, the tolerance was judged VERY GOOD by the dermatologists and the ophthalmologists and no functional signs were reported for the ophthalmological examination for all the subjects.
How to use it?
Apply to eye contour 1 to 2 times a day, in the morning and/or evening.